1Service FJ. Hypoglycemic disorders. N Engl J Med,1995,332:1144-1152.
2Daughaday WH. The pathophysiology of IGF-II hypersecretion in non-islet tumor hypoglycemia. Diabetes Rev,1995,3:62-72.
3Service FJ, McMahon MM, O'Brien PC, Ballard DJ: Functioning insulinoma: incidence, recurrence and long term survival of patients: a 60-year study. Mayo Clin Proc,1991,66:711-719.
4Bliss RD, Carter PB, Lennard TW. Insulinoma: a review of current management. Surg Oncol,1997,6:49-59.
6Dominguez S, Denys A, Madeira I et al. Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol,2000,12:151-157.
7Rivera E, Ajani JA. Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma. Am J Clin Oncol,1998,21:36-38.
